ponalrestat has been researched along with dinoprost in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dani, C; Lefrançois-Martinez, AM; Loubeau, G; Martin, G; Martinez, A; Pastel, E; Pointud, JC; Sahut-Barnola, I; Slim, K; Val, P; Volat, F | 1 |
Bouvet-Bouchard, L; Gauthier, MF; Julien, F; Labrecque, J; Michaud, A; Pelletier, M; Tchernof, A | 1 |
2 other study(ies) available for ponalrestat and dinoprost
Article | Year |
---|---|
Aldose reductases influence prostaglandin F2α levels and adipocyte differentiation in male mouse and human species.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adipose Tissue; Adult; Aldehyde Reductase; Animals; Cell Differentiation; Cloprostenol; Dinoprost; Enzyme Inhibitors; Gene Expression Profiling; Humans; Hydroxyprostaglandin Dehydrogenases; Luteolytic Agents; Male; Mice; Middle Aged; Multipotent Stem Cells; Obesity; Phthalazines; Receptors, Prostaglandin; RNA, Messenger; Subcutaneous Fat, Abdominal | 2015 |
Interleukin-1β and prostaglandin-synthesizing enzymes as modulators of human omental and subcutaneous adipose tissue function.
Topics: Adipocytes; Adipogenesis; Aldehyde Reductase; Cell Differentiation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Dinoprost; Dinoprostone; Female; Humans; Inflammation; Interleukin-1beta; Intra-Abdominal Fat; Male; Middle Aged; Nitrobenzenes; Obesity; Omentum; Phthalazines; PPAR gamma; Subcutaneous Fat, Abdominal; Sulfonamides | 2019 |